A review of antisense therapeutic interventions for molecular biological targets in asthma.
Modern tools of genomics and proteomics reveal potential therapeutic antisense targets in asthma, increasing the interest in the development of anti-mRNA drugs. In allergic asthma experimental models, antisense oligonucleotides (ASO) are administered by inhalation or systemically. ASO can be used for a large number of molecular targets: cell membrane receptors (G-protein coupled receptors, cytokine and chemokine receptors), membrane proteins, ion channels, cytokines and related factors, signaling non-receptor protein kinases (tyrosine kinases, and serine/threonine kinases) and regulators of transcription belonging to Cys4 zinc finger of nuclear receptor type or beta-scaffold factors with minor groove contacts classes/superclasses of transcription factors. A respirable ASO against the adenosine A(1) receptor was investigated in human trials. RNase P-associated external guide sequence (EGS) delivered into pulmonary tissues represents a potentially new therapeutic approach in asthma as well as ribozyme strategies. Small interfering RNA (siRNA) targeting key molecules involved in the patho-physiology of allergic asthma are expected to be of benefit as RNAi immunotherapy. Antagomirs, synthetic analogs of microRNA (miRNA), have important roles in regulation of gene expression in asthma. RNA interference (RNAi) technologies offer higher efficiency in suppressing the expression of specific genes, compared with traditional antisense approaches.
Popescu
Florin-Dan
FD
Department of Allergology, University of Medicine and Pharmacy, "Carol Davila", Bucharest, Romania.
Popescu
Florica
F
Nature. 2004 Sep 16;431(7006):338-42
15372040
J Biol Chem. 2003 Feb 14;278(7):4725-9
12493770
J Biomed Biotechnol. 2006;2006(4):63675
17057365
Oligonucleotides. 2005 Summer;15(2):132-8
15989427
Am J Pharmacogenomics. 2003;3(2):97-106
12749727
Am J Respir Crit Care Med. 2001 Mar;163(4):989-93
11282778
J Clin Pharmacol. 1999 Jan;39(1):47-54
9987700
BioDrugs. 2006;20(1):1-11
16573347
Curr Drug Targets. 2003 Nov;4(8):619-23
14577652
J Immunol. 2005 Aug 1;175(3):1867-75
16034130
FEBS Lett. 2002 Sep 11;527(1-3):274-8
12220673
J Cell Biochem. 2006 May 1;98(1):14-35
16440307
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):153-8
16371463
Nanomedicine (Lond). 2007 Apr;2(2):169-81
17716119
Blood. 2007 May 15;109(10):4399-405
17284533
Eur J Biochem. 2003 Apr;270(8):1628-44
12694176
FEBS Lett. 2005 Jan 3;579(1):173-8
15620709
Cell Cycle. 2007 Feb 15;6(4):444-9
17312397
Int J Mol Med. 2005 Mar;15(3):391-9
15702227
Nature. 2004 Nov 11;432(7014):173-8
15538359
Blood. 2000 Feb 15;95(4):1249-57
10666197
Nat Biotechnol. 2004 Dec;22(12):1579-82
15558046
Chest. 2003 Mar;123(3 Suppl):363S-8S
12628976
Am J Respir Crit Care Med. 2005 Mar 15;171(6):571-8
15557129
Nat Rev Immunol. 2004 Apr;4(4):249-58
15057783
IDrugs. 2001 Jun;4(6):646-9
16001306
Nature. 2005 Dec 1;438(7068):685-9
16258535
Respir Res. 2001;2(1):5-9
11686859
J Exp Med. 1998 Aug 3;188(3):421-9
9687520
Histochem Cell Biol. 2006 Oct;126(4):495-505
16708245
J Biol Chem. 1995 Feb 10;270(6):2620-7
7852327
J Exp Med. 2001 Jun 4;193(11):1247-60
11390432
Int Immunopharmacol. 2004 Aug;4(8):1015-27
15222976
Am J Respir Cell Mol Biol. 2007 Jan;36(1):8-12
16917074
Springer Semin Immunopathol. 2004 Feb;25(3-4):281-94
15007632
J Cell Mol Med. 2005 Oct-Dec;9(4):840-53
16364194
Cancer Gene Ther. 2005 Oct;12(10):787-95
15891770
J Immunol. 2000 May 15;164(10):5409-15
10799906
Am J Respir Cell Mol Biol. 1999 Dec;21(6):728-37
10572070
J Immunol. 2002 Feb 15;168(4):1978-83
11823534
Acta Pharmacol Sin. 2005 Jul;26(7):780-8
15960883
Curr Pharm Des. 2006;12(25):3293-304
17020535
Am J Respir Crit Care Med. 2002 Apr 1;165(7):1015-21
11934731
Am J Respir Crit Care Med. 2004 Mar 1;169(5):596-603
14670803
Biochem Biophys Res Commun. 2006 Dec 15;351(2):431-7
17070777
Clin Rev Allergy Immunol. 2004 Dec;27(3):207-17
15630157
Nature. 2004 Sep 9;431(7005):211-7
15311210
Expert Opin Drug Deliv. 2005 Jan;2(1):3-28
16296732
Nature. 2006 May 4;441(7089):111-4
16565705
Adv Cancer Res. 2007;96:103-43
17161678
Pharmacol Rev. 2006 Jun;58(2):259-79
16714488
Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):533-40
16700890
Oligonucleotides. 2003;13(5):353-63
15000826
J Allergy Clin Immunol. 1999 Jul;104(1):205-14
10400863
Ann N Y Acad Sci. 2006 Oct;1082:62-73
17145927
Nat Rev Genet. 2007 Mar;8(3):173-84
17304245
Nucleic Acids Res. 2006 May 11;34(8):2294-304
16690972
N Engl J Med. 2006 Aug 31;355(9):953-4
16943409
Curr Opin Mol Ther. 2002 Oct;4(5):419-22
12435042
Ann N Y Acad Sci. 2006 Oct;1082:18-26
17145920
Allergy. 2007 Feb;62(2):102-12
17298416
Curr Opin Allergy Clin Immunol. 2002 Dec;2(6):533-6
14752337
Nature. 1998 Feb 19;391(6669):806-11
9486653
J Pharmacol Exp Ther. 2005 Sep;314(3):972-9
15919763
J Allergy Clin Immunol. 2004 Aug;114(2):288-95
15316505
Mutat Res. 2004 Sep;567(1):71-84
15341903
J Mol Histol. 2004 Aug;35(6):545-53
15614608
J Cell Mol Med. 2003 Oct-Dec;7(4):475-86
14754517
Curr Opin Investig Drugs. 2003 May;4(5):552-5
12833648
Ann N Y Acad Sci. 2006 Oct;1082:91-102
17145930
Am J Respir Cell Mol Biol. 2001 Feb;24(2):116-22
11159044
Nat Biotechnol. 2003 Dec;21(12):1457-65
14647331
Int Immunopharmacol. 2004 Dec 20;4(14):1817-28
15531297
J Allergy Clin Immunol. 2001 Feb;107(2):279-86
11174194
Mol Ther. 2006 Oct;14(4):463-70
16877044
J Biol Chem. 2000 Feb 18;275(7):4647-53
10671493
Curr Drug Targets Inflamm Allergy. 2005 Apr;4(2):267-70
15853749
J Pharmacol Exp Ther. 2007 Jun;321(3):938-46
17389243
J Immunol. 2002 Jul 15;169(2):1028-36
12097411
Expert Opin Ther Targets. 2005 Oct;9(5):901-21
16185147
Nat Biotechnol. 2004 Dec;22(12):1533-7
15583662
Curr Drug Targets. 2004 Jul;5(5):419-30
15216908
Science. 1994 Mar 4;263(5151):1269-73
8122108
Int J Mol Med. 2004 Jul;14(1):3-22
15202012
Histol Histopathol. 2007 Feb;22(2):211-7
17149694
J Exp Med. 2005 Jun 20;201(12):1875-9
15967818
Curr Allergy Asthma Rep. 2003 Jan;3(1):70-8
12542998
J Immunol. 2000 Apr 1;164(7):3790-7
10725739
Rev Med Suisse. 2007 Jan 17;3(94):103-6
17354533
Ann Allergy Asthma Immunol. 2006 Nov;97(5):567-76; quiz 576-8, 602
17165262
J Mol Biol. 2003 Apr 4;327(4):761-6
12654261
Antisense Nucleic Acid Drug Dev. 2002 Jun;12(3):177-81
12162700
Allergy. 2007 Feb;62(2):95-101
17298415
Semin Hematol. 1999 Oct;36(4 Suppl 6):9-14
10530711
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5175-80
11296262
Antisense Nucleic Acid Drug Dev. 1999 Feb;9(1):71-80
10192291
Nature. 2006 May 25;441(7092):537-41
16724069
Oligonucleotides. 2006 Fall;16(3):239-52
16978087
J Mol Biol. 2004 Sep 24;342(4):1077-83
15351636